Dear Friends & Colleagues,
I am glad to bring you warm Deepavali Wishes and the Season’s Greetings from Oviya MedSafe – your potential strategic partner for Global Pharmacovigilance, through the November 2012 edition of our monthly newsletter!  
In this edition, I am happy to share with you a milestone that Oviya MedSafe has reached a few days ago – our first peer-reviewed publication!
At this juncture, I thank renowned diabetologist Dr V Mohan and his team (especially Dr S Chandru) who invited Oviya MedSafe to work along with them on an article emphasizing on the need for pharmacovigilance of the anti-diabetic drug Pioglitazone the usage of which has been linked to the causation of cancer of the urinary bladder.
Our peer-reviewed article titled ‘Need to Increase Awareness Among Urologists Regarding the Possible Association Between Pioglitazone and Bladder Cancer’ has been published in the Indian Journal of Clinical Medicine on 08-Nov-2012. The free full-text of the article can be downloaded and read by visiting the URL of the publisher
We hope you will find the article interesting and we are keen to receive your feedback on this article.
Do visit us at and feel free to write to with your thoughts.
Follow us on:
With thanks & regards,
Dr Vijay Venkatraman Janarthanan.
Founder & CEO,
Oviya MedSafe Pvt. Ltd.
2nd Floor, KTVR Gardens
220a-3, Marudha Konar Road,
Coimbatore – 641 025.
Tamil Nadu, India.

Leave a comment

Your email address will not be published. Required fields are marked *